Lindenwold Advisors Merit Medical Systems Inc Transaction History

Lindenwold Advisors

$187 Million
Q2 2025

A detailed history of Lindenwold Advisors transactions in Merit Medical Systems Inc stock. As of the latest transaction made, Lindenwold Advisors holds 2,592 shares of MMSI stock, worth $218,272. This represents 0.13% of its overall portfolio holdings.

Number of Shares

2,592

Previous 2,681 3.32%

Holding current value

$218,272

Previous $283,000 14.49%

% of portfolio

0.13%

Previous 0.16%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$88.48 - $107.04 $7,874 - $9,526	-89 Reduced 3.32%	2,592 $242,000
Q1 2025 May 08, 2025	SELL	$95.64 - $110.29 $44,472 - $51,284	-465 Reduced 14.78%	2,681 $283,000
Q4 2024 Feb 10, 2025	BUY	$93.76 - $105.52 $937 - $1,055	10 Added 0.32%	3,146 $304,000
Q3 2024 Nov 07, 2024	BUY	$84.12 - $100.23 $841 - $1,002	10 Added 0.32%	3,136 $309,000
Q1 2024 May 09, 2024	BUY	$71.86 - $81.25 $718 - $812	10 Added 0.32%	3,126 $236,000
Q3 2023 Oct 19, 2023	BUY	$63.36 - $84.73 $3,801 - $5,083	60 Added 1.96%	3,116 $215,000
Q2 2023 Aug 07, 2023	SELL	$74.03 - $85.24 $11,474 - $13,212	-155 Reduced 4.83%	3,056 $255,000
Q1 2023 May 05, 2023	SELL	$66.13 - $73.95 $991 - $1,109	-15 Reduced 0.46%	3,211 $237,000
Q4 2022 Feb 13, 2023	BUY	$54.72 - $74.43 $176,526 - $240,111	3,226 New	3,226 $227,000
Q2 2022 Aug 05, 2022	SELL	$51.75 - $70.49 $198,513 - $270,399	-3,836 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$52.65 - $66.52 $10,530 - $13,304	200 Added 5.5%	3,836 $255,000
Q4 2021 Feb 14, 2022	BUY	$59.58 - $72.61 $216,632 - $264,009	3,636 New	3,636 $227,000

Others Institutions Holding MMSI

# of Institutions

412

Shares Held

62.3M

Call Options Held

900K

Put Options Held

29.5K

View Full List

About MERIT MEDICAL SYSTEMS INC

Ticker MMSI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 56,919,400
Market Cap $4.79B
Description
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention produc...

More about MMSI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindenwold Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Lindenwold Advisors with notifications on news.

Account

Lindenwold Advisors Merit Medical Systems Inc Transaction History